Answers are grounded in this paper and cite their sources.
Parkinson’s disease features dopaminergic neuron loss, α-synuclein pathology, and motor and non-motor manifestations. Ferroptosis is associated to regional iron dyshomeostasis, impaired glutathione defenses, mitochondrial dysfunction, dopamine oxidation, and membrane injury. In preclinical models, natural compounds and traditional Chinese medicine formulas modulate iron handling, NRF2-system x c - -GSH–GPX4 signaling, ferritinophagy, lipid remodeling, and mitochondrial quality control. This review examines these mechanisms and translational requirements for ferroptosis-directed PD interventions.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: